Ripretinib for treating advanced gastrointestinal stromal tumours after 3 or more treatments (review of TA881) [ID6496]

Draft guidance

Draft guidance (downloadable version) (PDF 217 KB)

Draft guidance (online commenting)

Committee papers (PDF 6.42 MB)

Public committee slides (PDF 640 KB)

Final scope (PDF 90 KB)

Draft scope and provisional stakeholder list comments table (post-referral) (PDF 130 KB)

Equality impact assessment (scoping) (PDF 48 KB)

Draft scope post referral (PDF 130 KB)